Cell Culture Market

Cell Culture Market by Product (Consumables (Media, Serum, Vessels), Equipment (Bioreactor, Centrifuge, Incubator, Autoclave)), Application (Therapeutic Proteins, Vaccines, Diagnostics, Stem cells), End User (Pharma, Biotech) - Global Forecast to 2025

Report Code: BT 2561 Nov, 2020, by marketsandmarkets.com

[375 Pages Report] The cell culture market is projected to reach USD 33.1 billion by 2025 from USD 19.0 billion in 2020, at a CAGR of 11.8% during the forecast period. The growth of this market is majorly driven by the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced cell culture products.

The growing demand for 3D cell culture, the growing risks of pandemics and communicable diseases, and emerging markets are expected to offer significant growth opportunities for the players operating in the global Cell culture market. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining this market's growth.

Cell Culture Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on Global Cell Culture Market

The COVID-19 pandemic has resulted in a tremendous increase of burden on healthcare organizations across the globe. According to the WHO, there were 43,540,739 confirmed cases of COVID-19, including 1,160,650 deaths (as of October 28, 2020). The highest number of deaths was in the Americas, followed by Europe and Southeast Asia. Furthermore, due to the COVID-19 pandemic, governments across the globe have announced country-wide lockdowns and social distancing measures to prevent the collapse of their health systems.

Currently, no effective treatment for COVID-19 is available in vaccines or antiviral drugs, and patients are currently treated symptomatically. According to the WHO, there are 70 vaccine candidates under development, and three candidates are already being tested in human trials. At the forefront of the COVID-19 outbreak, many researchers worldwide are engaged in the viral research of SARS-CoV-2, the virus that causes COVID-19.

Cell culture-based viral vaccines are used globally to immunize humans against infections. Currently, mammalian cell lines are used to culture the SARS-CoV-2 virus for research purposes. In bioproduction, culture mediums provide nutrients and component cells required to grow under controlled environmental conditions to produce therapeutics with the desired level of pharmaceutical efficacy. Cell culture products such as cell culture medium, reagents, and equipment help researchers investigate cellular behavior, which will help with vaccine development. It is expected to speed up vaccine research and development processes using cell culture technology.

Cell culture is a continuous process of developing substrates for the safe production of viral vaccines. However, increasing global demand and strict safety rules for novel vaccines to control and eradicate the coronavirus's spread has forced researchers and manufacturers toward the development of cell culture-based vaccines. This development has significantly increased the demand for cell culture products during the first three quarters of 2020 and is further expected to increase in the last quarter of 2020 and 2021.

Cell Culture Market Dynamics

Driver:  Funding for cell-based research

Cell culture is used for developing biological products for the treatment of various diseases, such as cancer and cardiovascular diseases. Globally, major R&D activities are being carried out to develop new & innovative cell therapy products funded by the government and private organizations. For instance, in November 2017, the California Institute for Regenerative Medicine (CIRM) invested USD 16.4 million for stem cell research focusing on new therapies for leukemia, respiratory problems, and skin disease. In March 2020, the Government of Canada invested around USD 7.0 million through the Stem Cell Network’s competitive research funding program to support stem cell research in Canada. Similarly, in March 2019, the Government of Canada invested approximately USD 13.6 million (Can $18 million) through the Stem Cell Network (SCN) for stem cell and regenerative medicine research.

Restraint:  High cost of cell biology research

Cell biology involves extensive R&D on new therapies, such as stem cell and gene therapies. The equipment, reagents, and other products associated with this research must be of the highest quality to provide accurate results. The cost of cell biology research is high owing to the growing need to maintain high-quality standards (through the use of high-grade products) and comply with guidelines set up by regulatory bodies. As a result, various academic institutes and small-scale companies with controlled budgets cannot conduct cell biology research. This, in turn, is restraining the growth of the cell culture market.

Opportunity: The growing risk of pandemics and communicable diseases

Various factors, such as population growth, climate change, and increasing contact between humans and animals, have increased the threat of new virus outbreaks such as the COVID-19. These situations are unpredictable and recurring events that are highly likely to pose a significant economic and social burden. Globally, as of 28th October 2020, there have been 43.54 million confirmed cases of COVID-19, including 1.16 million deaths, as reported by the World Health Organization (WHO).

According to the Centers for Disease Control (CDC), 30,453 laboratory-confirmed influenza-related hospitalizations were reported in the US through the Influenza Hospitalization Surveillance Network (FluSurv-NET) from October 2017 to April 2018. Similarly, according to the Infection Prevention and Control, in Canada, a pandemic of seasonal influenza began in August 2015, and by November 2015, there were 31 confirmed cases of influenza in the country. The majority of pandemic influenza cases in Canada are due to the influenza A (H3N2) virus.

As of February 2017, more than 525,000 cases of H1N1 have been recorded worldwide (Source: WHO). Similarly, according to the WHO, in 2016, around 20.4 million people were affected by measles globally. The increasing incidence of such infectious diseases and the growing risk of pandemics are the major factors expected to drive the demand for vaccines across the globe. This, in turn, is expected to offer potential growth opportunities for players operating in the cell culture market during the forecast period.

The consumables segment accounts for the largest share of the market, by product, in 2019

By product, the cell culture market is segmented into equipment and consumables. The consumables segment accounted for the largest market share in 2019 and is expected to register the highest CAGR during the forecast period. The dominant share and high growth of the consumables segment can be attributed to the repeated purchase of consumables and increased funding for cell-based research.

The biopharmaceutical production application segment is expected to grow at the highest CAGR during the forecast period

Based on application, the cell culture market is categorized into biopharmaceutical production, stem cell research, diagnostics, drug screening & development, tissue engineering and regenerative medicine, and other applications. The biopharmaceutical production application segment is expected to register the highest CAGR during the forecast period. This segment's high growth is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and an increase in the demand for monoclonal antibodies (mAbs).

Pharmaceutical & biotechnology compaes end-user segment is expected to grow at the highest CAGR in the cell culture market during the forecast period

Based on end users, the cell culture market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals and diagnostic centers, and cell banks. The pharmaceutical & biotechnology companies segment accounted for the largest market share in 2019 and is projected to register the highest CAGR during the forecast period. The growing use of single-use technologies, the increasing number of regulatory approvals for cell culture-based vaccines, and the presence of a large number of pharmaceutical players in this market are driving the cell culture market for this segment

North America is expected to account for the largest share of the cell culture market in 2019

In 2019, North America accounted for the largest share of the cell culture market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the growing regulatory approvals for cell culture-based vaccines, rising incidence of diseases such as cancer, growing academic and government investments in cell-based research,  strong government support, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America are the key factors driving the growth of the cell culture market in North America. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.

Cell Culture Market  by Region

Key Market Players

The prominent players in this market are Thermo Fisher Scientific (US)Merck KGaA (Germany)GE Healthcare (US),Danaher Corporation (US)Becton, Dickinson and Company (US), Corning Incorporated (US), Eppendorf (Germany), HiMedia Laboratories (India), Sartorius AG (Germany), PromoCell GmbH (Germany), FUJIFILM Irvine Scientific (US), InvivoGen (US), CellGenix GmbH (Germany), SeraCare Life Sciences Incorporation (US), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Solida Biotech GmBH (Germany), Caisson Labs Inc. (US), Cellexus Ltd, (UK), PIERRE GUΙRIN (France), Applikon Biotechnology BV (Netherlands), WISENT Inc. (Canada), Koh Jin-Bio Co., Ltd. (Japan), PAN-Biotech GmbH (Germany), and Infors AG (Switzerland).

Scope of Market

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

Product, Application, End User

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Companies covered

Thermo Fisher Scientific (US), Merck KGaA (Germany), GE Healthcare (US), Danaher Corporation (US), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), Corning Incorporated (US), Eppendorf (Germany), HiMedia Laboratories (India), Sartorius AG (Germany), PromoCell GmbH (Germany), FUJIFILM Irvine Scientific (US), InvivoGen (US), CellGenix GmbH (Germany), SeraCare Life Sciences Incorporation (US), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Solida Biotech GmBH (Germany), Caisson Labs Inc. (US), Cellexus Ltd, (UK), PIERRE GUΙRIN (France), Applikon Biotechnology BV (Netherlands), WISENT Inc. (Canada), Koh Jin-Bio Co., Ltd. (Japan), PAN-Biotech GmbH (Germany), and Infors AG (Switzerland).

The study categorizes the Cell culture market based on product, application, end user, and regional and global level.

Global Cell culture market, by Product

  • Consumables
    • Sera, Media, and Reagents
      • Media
        • Serum-Free Media
        • Classical Media & Salts
        • Stem Cell Culture Media
        • Specialty Media
      • Reagents
        • Supplements & Growth Factors
        • Buffers & Chemicals
        • Cell Dissociation Reagents
        • Balanced Salt Solutions
        • Attachment & Matrix Factors
        • Antibiotics/Antimycotics
        • Contamination Detection Kits
        • Cryoprotective Reagents
        • Other Cell Culture Reagents
      • Sera
        • Fetal Bovine Sera
        • Adult Bovine Sera
        • Other Animal Sera
    • Vessels
      • Roller/Roux Bottles
      • Cell Factory Systems/Cell Stacks
      • Multiwell Plates
      • Flasks
      • Petri Dishes
    • Bioreactor Accessories
  • Equipment
    • Supporting Equipment
      • Filtration Systems
      • Cell Counters
      • Carbon Dioxide Incubators
      • Centrifuges
      • Autoclaves
      • Microscopes
      • Biosafety Cabinets
      • Other Supporting Equipment
    • Bioreactors
      • Conventional Bioreactors
      • Single-Use Bioreactors
    • Storage Equipment
      • Refrigerators & Freezers
      • Cryostorage Systems

Global Cell culture market, by Application

  • Biopharmaceutical Production
    • Therapeutic Proteins
    • Vaccine Production
  • Diagnostics
  • Drug Screening and Development
  • Stem Cell Research
  • Tissue Engineering & Regenerative Medicine
  • Other Applications >

Global Cell culture market, by End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals and Diagnostic Laboratories
  • Academic & Research Institutes
  • Cell Banks

Global Cell culture market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments

  • In October 2020, Eppendorf (Germany) launched Refrigerated Centrifuge 5425 R
  • In September 2020, Thermo Fisher Scientific (US) opened a new bioprocessing collaboration center in St. Louis, Missouri, US.
  • In September 2020, Cytiva plans to increase its manufacturing capacity with an investment of USD 500 million.
  • In April 2020, Danaher Corporation completed the acquisition of GE Healthcare’s biopharma business. Under Danaher’s ownership, the business will be called Cytiva.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATION
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
    2.1 RESEARCH DATA
    2.2 SECONDARY DATA
           2.2.1 SECONDARY SOURCE
    2.3 PRIMARY DATA
           2.3.1 KEY DATA FROM PRIMARY SOURCES
    2.4 MARKET SIZE ESTIMATION
    2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.6 ASSUMPTIONS FOR THE STUDY
    2.7 COVID-19 HEALTH ASSESSMENT
    2.8 COVID-19 ECONOMIC ASSESSMENT
    2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    2.1 ASSESSMENT OF THE IMPACT OF THE COVID-19 ON THE ECONOMIC SCENARIO OF THE CELL CULTURE MARKET

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
    4.1 CELL CULTURE: MARKET OVERVIEW
    4.2 ASIA PACIFIC: CELL CULTURE MARKET SHARE, BY END USER AND COUNTRY (2019)
    4.3 CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    4.4 REGIONAL MIX: CELL CULTURE MARKET
    4.5 CELL CULTURE MARKET: DEVELOPED VS. DEVELOPING MARKETS

5 MARKET OVERVIEW
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 MARKET DRIVERS
                    5.2.1.1 Growing awareness about the benefits of cell culture-based vaccines
                    5.2.1.2 Increasing demand for monoclonal antibodies
                    5.2.1.3 Funding for cell-based research
                    5.2.1.4 Growing preference for single-use technologies
                    5.2.1.5 Launch of advanced cell culture products
                    5.2.1.6 Growing focus on personalized medicine
           5.2.2 MARKET RESTRAINTS
                    5.2.2.1 High cost of cell biology research
                    5.2.2.2 Lack of infrastructure for cell-based research in emerging economies
           5.2.3 MARKET OPPORTUNITIES
                    5.2.3.1 Growing demand for 3D cell culture
                    5.2.3.2 The growing risk of pandemics and communicable diseases
                    5.2.3.3 Emerging economies
    5.3 COVID-19 IMPACT ON THE CELL CULTURE MARKET
    5.4 VALUE CHAIN ANALYSIS
    5.5 SUPPLY CHAIN ANALYSIS
    5.6 ECOSYSTEM ANALYSIS
    5.7 REGULATORY ANALYSIS

6 CELL CULTURE MARKET, BY PRODUCT
    6.1 INTRODUCTION
    6.2 IMPACT OF THE COVID-19 ON THE CELL CULTURE MARKET
    6.3 CONSUMABLES
           6.3.1 SERA, MEDIA, AND REAGENTS
                    6.3.1.1 Media
                               6.3.1.1.1 Serum-free media
                                             6.3.1.1.1.1 Lack of sera eliminates the risk of contamination by viruses
                               6.3.1.1.2 Classical media & salts
                                             6.3.1.1.2.1 Classical media is commonly used in virology, vaccine production, and primary tissue explant culture
                               6.3.1.1.3 Stem cell culture media
                                             6.3.1.1.3.1 Stem cell culture media to witness the highest growth in the APAC market during the forecast period
                               6.3.1.1.4 Specialty media
                                             6.3.1.1.4.1 Specialty media is suitable for the growth of selective cell types
                    6.3.1.2 Reagents
                               6.3.1.2.1 Growth factors
                                             6.3.1.2.1.1 Growth factors are unique cell signaling molecules that help in cell proliferation & development
                               6.3.1.2.2 Supplements
                                             6.3.1.2.2.1 Supplements such as amino acids play a key role in inducing cell growth
                               6.3.1.2.3 Buffers & chemicals
                                             6.3.1.2.3.1 Chemical buffers are widely used, but it can be toxic at higher concentrations
                               6.3.1.2.4 Cell dissociation reagents
                                             6.3.1.2.4.1 Dissociation reagents can be enzymatic or non-enzymatic
                               6.3.1.2.5 Balanced salt solutions
                                             6.3.1.2.5.1 Balanced salt solutions find wide applications in life sciences
                               6.3.1.2.6 Attachment & matrix factors
                                             6.3.1.2.6.1 The development of cells is dependent on attachment factors
                               6.3.1.2.7 Antibiotics/Antimycotics
                                             6.3.1.2.7.1 The possibility of contamination risks make the long-term use of antibiotics/antimycotics conditional
                               6.3.1.2.8 Contamination detection kits
                                             6.3.1.2.8.1 Contamination detection kits provide rapid results
                               6.3.1.2.9 Cryoprotective reagents
                                             6.3.1.2.9.1 Cryoprotective reagents protect tissues/cells from damage due to freezing
                                             6.3.1.2.10 Other cell culture reagents
                    6.3.1.3 Sera
                               6.3.1.3.1 Fetal bovine sera(FBS)
                                             6.3.1.3.1.1 Use of FBS is now restricted due to regulatory guidelines
                               6.3.1.3.2 Adult bovine sera (ABS)
                                             6.3.1.3.2.1 ABS is a cost-effective alternative to FBS and is used as a biochemical reagent in IVD
                               6.3.1.3.3 Other animal sera
           6.3.2 VESSELS
                    6.3.2.1 Roller/roux bottles
                               6.3.2.1.1 Roller bottles offer an economical means of cultivating large cell volumes
                    6.3.2.2 Cell factory systems/cell stacks
                               6.3.2.2.1 Cell stacks require special handling equipment and skilled expertise
                    6.3.2.3 Multiwell plates
                               6.3.2.3.1 Larger well formats allow for greater culture volumes
                    6.3.2.4 Flasks
                               6.3.2.4.1 Disposable flasks are in greater demand among end users
                    6.3.2.5 Petri dishes
                               6.3.2.5.1 The wide usage of Petri dishes is attributed to ease of use
           6.3.3 BIOREACTOR ACCESSORIES
    6.4 EQUIPMENT
           6.4.1 SUPPORTING EQUIPMENT
                    6.4.1.1 Filtration systems
                               6.4.1.1.1 Growing research activities in cell biology is a key factor driving market growth
                    6.4.1.2 Cell counters
                               6.4.1.2.1 Automated cell counters are witnessing growing demand for the determination of cell count & viability
                    6.4.1.3 Carbon dioxide incubators
                               6.4.1.3.1 Incubators provide control over atmospheric conditions
                    6.4.1.4 Centrifuges
                               6.4.1.4.1 Technological advances have enabled the development of faster & compact centrifuges
                    6.4.1.5 Autoclaves
                               6.4.1.5.1 Autoclaves sterilize equipment and supplies for use
                    6.4.1.6 Microscopes
                               6.4.1.6.1 Inverted microscopes are widely used in cell culture processes
                    6.4.1.7 Biosafety cabinets
                               6.4.1.7.1 Cabinets are classified into three classes based on the types of protection offered
                    6.4.1.8 Other supporting equipment
           6.4.2 BIOREACTORS
                    6.4.2.1 Conventional bioreactors
                               6.4.2.1.1 Conventional bioreactors held the largest share of the bioreactors market in 2019
                    6.4.2.2 Single-use bioreactors
                               6.4.2.2.1 Convenience, ease of use, and flexibility are driving the demand for SUBs
           6.4.3 STORAGE EQUIPMENT
                    6.4.3.1 Refrigerators & freezers
                               6.4.3.1.1 Refrigerators & freezers are used for both short and long-term storage
                    6.4.3.2 Cryostorage systems
                               6.4.3.2.1 Benefits of long-term preservation of cell cultures are driving segment growth

7 CELL CULTURE MARKET, BY APPLICATION
    7.1 INTRODUCTION
    7.2 IMPACT OF THE COVID-19 ON THE CELL CULTURE MARKET
    7.3 BIOPHARMACEUTICAL PRODUCTION
           7.3.1 THERAPEUTIC PROTEINS
                    7.3.1.1 Growing applications of recombinant proteins to drive the growth of this segment

                    7.3.2.1 Rising incidence of disease outbreaks to drive the market growth for vaccine production
    7.4 DIAGNOSTICS
           7.4.1 THE GROWING RISK OF VIRAL INFECTIONS DRIVES THE UPTAKE OF CELL CULTURE PRODUCTS FOR DIAGNOSTICS
    7.5 DRUG SCREENING & DEVELOPMENT
           7.5.1 INCREASING ADOPTION OF CELL-BASED ASSAYS IN R&D ACTIVITIES TO DRIVE SEGMENT GROWTH
    7.6 STEM CELL RESEARCH
           7.6.1 INCREASING STEM CELL RESEARCH ACTIVITIES & INVESTMENTS DRIVE SEGMENT GROWTH
    7.7 TISSUE ENGINEERING AND REGENERATIVE MEDICINE
           7.7.1 INCREASING FUNDING FOR REGENERATIVE MEDICINE BOOSTS SEGMENT GROWTH
    7.8 OTHER APPLICATIONS

8 CELL CULTURE MARKET, BY END USER
    8.1 INTRODUCTION
    8.2 IMPACT OF THE COVID-19 ON THE CELL CULTURE END-USER MARKET
    8.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           8.3.1 GROWING REGULATORY APPROVALS FOR CELL-CULTURE BASED VACCINES DRIVES SEGMENT GROWTH
    8.4 HOSPITALS AND DIAGNOSTIC LABORATORIES
           8.4.1 INCREASING APPLICATIONS OF CELL CULTURE FOR THE DIAGNOSIS OF VARIOUS DISEASES TO DRIVE SEGMENT GROWTH
    8.5 RESEARCH & ACADEMIC INSTITUTES
           8.5.1 INCREASING GOVERNMENT FUNDING FOR RESEARCH PROJECTS AND THE HIGH PREVALENCE OF CANCER TO DRIVE GROWTH FOR THIS END-USER SEGMENT
    8.6 CELL BANKS
           8.6.1 INCREASING AWARENESS OF PRESERVING STEM CELLS TO DRIVE SEGMENT GROWTH

9 CELL CULTURE MARKET, BY REGION
    9.1 INTRODUCTION
    9.2 COVID IMPACT ON THE CELL CULTURE MARKET
    9.3 NORTH AMERICA
           9.3.1 US
                    9.3.1.1 The presence of an established pharmaceutical & biotechnology sector drives market growth for cell culture
           9.3.2 CANADA
                    9.3.2.1 Advancement in the field of regenerative medicine to drive market growth in Canada
    9.4 EUROPE
           9.4.1 GERMANY
                    9.4.1.1 Increasing R&D investments by various key players and funding from government organizations to drive market growth
           9.4.2 FRANCE
                    9.4.2.1 Support from government and private investors to drive the cell culture market in France
           9.4.3 UK
                    9.4.3.1 Growth in the life science industry to drive the market for cell culture in the UK
           9.4.4 ITALY
                    9.4.4.1 Leading life science research hub and cell biology conferences to fuel the adoption of cell culture products in Italy
           9.4.5 SPAIN
                    9.4.5.1 Increasing funding from private & public organizations to aid market growth in Spain
           9.4.6 ROE
    9.5 ASIA PACIFIC
           9.5.1 CHINA
                    9.5.1.1 China to register the highest growth rate in the Asia Pacific cell culture market during the forecast period
           9.5.2 JAPAN
                    9.5.2.1 Strategic developments by companies to drive the market for cell culture in Japan
           9.5.3 INDIA
                    9.5.3.1 Growth initiatives to promote the life science industry to drive the cell culture market in India
           9.5.4 ROAPAC
    9.6 LATIN AMERICA
           9.6.1 BRAZIL
                    9.6.1.1 Increasing healthcare spending on biologics & life science research to drive market growth in Brazil
           9.6.2 MEXICO
                    9.6.2.1 Growth in pharmaceutical manufacturing drives R&D investments for cell culture in Mexico
           9.6.3 REST OF LATIN AMERICA (ROLA)
    9.7 MIDDLE EAST AND AFRICA
           9.7.1 INCREASING R&D FUNDING FOR STEM CELL THERAPY DRIVES THE MARKET GROWTH

10 COMPETITIVE LANDSCAPE
     10.1 OVERVIEW
     10.2 COMPETITIVE SCENARIO
             10.2.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2020)
             10.2.2 PRODUCT LAUNCHES & UPGRADES (2020)
             10.2.3 EXPANSIONS (2020)
             10.2.4 ACQUISITIONS (2019–2020)

11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES
     11.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
     11.2 COMPETITIVE LEADERSHIP MAPPING (2019)
             11.2.1 STARS
             11.2.2 EMERGING LEADERS
             11.2.3 PERVASIVE COMPANIES
             11.2.4 EMERGING COMPANIES
     11.3 MARKET SHARE ANALYSIS, 2019
     11.4 COMPANY PROFILES
             11.4.1 THERMO FISHER SCIENTIFIC INC.
             11.4.2 MERCK KGAA
             11.4.3 BECTON, DICKINSON AND COMPANY
             11.4.4 CORNING INCORPORATED
             11.4.5 DANAHER CORPORATION
             11.4.6 EPPENDORF AG
             11.4.7 FUJIFILM IRVINE SCIENTIFIC, INC. (ACQUIRED BY FUJIFILM CORPORATION)
             11.4.8 LONZA GROUP AG
             11.4.9 SARTORIUS AG
             11.4.10 CELLGENIX GMBH
             11.4.11 MILTENYI BIOTEC
             11.4.12 STEMCELL TECHNOLOGIES, INC.
             11.4.13 HIMEDIA LABORATORIES
             11.4.14 INVIVOGEN
             11.4.15 INFORS AG
             11.4.16 PROMOCELL
             11.4.17 PAN BIOTECH GMBH
             11.4.18 SERACARE LIFE SCIENCES INCORPORATION
             11.4.19 CAISSON LABS
             11.4.20 SOLIDA BIOTECH GMBH

12 APPENDIX
     12.1 INSIGHTS FROM INDUSTRY EXPERTS
     12.2 DISCUSSION GUIDE
     12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.4 AVAILABLE CUSTOMIZATIONS
     12.5 RELATED REPORTS
     12.6 AUTHOR DETAILS


LIST OF TABLES (375 Tables)

TABLE 1 APPROVED CELL CULTURE-BASED VACCINES FOR INFLUENZA
TABLE 2 APPROVED MONOCLONAL ANTIBODIES BY EMA/FDA FOR THERAPEUTIC USE
TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINE
TABLE 4 CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 5 CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 6 CELL CULTURE CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 8 SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 CELL CULTURE MEDIA MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 12 SERUM-FREE MEDIA MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
TABLE 14 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 16 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 18 SPECIALTY MEDIA MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 19 CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 20 CELL CULTURE REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 GROWTH FACTORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 SUPPLEMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 23 BUFFERS & CHEMICALS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 25 BALANCED SALT SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 27 ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 28 CONTAMINATION DETECTION KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 OTHER CELL CULTURE REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 31 CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 32 CELL CULTURE SERA MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 33 FETAL BOVINE SERA MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 34 ADULT BOVINE SERA MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 35 OTHER ANIMAL SERA MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 36 VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 37 VESSELS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 38 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 39 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 40 MULTIWELL PLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 41 FLASKS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 42 PETRI DISHES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 43 BIOREACTOR ACCESSORIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 44 CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 45 CELL CULTURE EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 46 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 47 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 48 FILTRATION SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 49 FILTRATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 50 CELL COUNTERS OFFERED BY KEY MARKET PLAYERS
TABLE 51 CELL COUNTERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 52 CARBON DIOXIDE INCUBATORS OFFERED BY KEY MARKET PLAYERS
TABLE 53 CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 54 CENTRIFUGES OFFERED BY KEY MARKET PLAYERS
TABLE 55 CENTRIFUGES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 56 AUTOCLAVES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 57 MICROSCOPES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 58 BIOSAFETY CABINETS OFFERED BY KEY MARKET PLAYERS
TABLE 59 BIOSAFETY CABINETS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 60 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 61 CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 62 CELL CULTURE BIOREACTORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 63 CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 64 SINGLE-USE BIOREACTORS OFFERED BY KEY MARKET PLAYERS
TABLE 65 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 66 CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 67 CELL CULTURE STORAGE EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 68 REFRIGERATORS & FREEZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 69 CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 70 CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 71 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY/ REGION, 2018–2025 (USD MILLION)
TABLE 73 THERAPEUTIC PROTEINS MARKET, BY COUNTRY/ REGION, 2018-2025 (USD MILLION)
TABLE 74 VACCINE PRODUCTION MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 75 CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 76 CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 77 CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 78 CELL CULTURE MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 79 CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 80 CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 81 CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 82 CELL CULTURE MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 83 CELL CULTURE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 84 CELL CULTURE MARKET FOR CELL BANKS, BY REGION, 2018–2025 (USD MILLION)
TABLE 85 CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 86 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 87 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 88 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 93 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 96 NORTH AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 NORTH AMERICA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 99 NORTH AMERICA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 NORTH AMERICA: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 101 US: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 102 US: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 US: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 106 US: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 107 US: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 US: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 US: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 110 US: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 111 US: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 112 US: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 113 US: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 US: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 115 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 116 CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 CANADA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 118 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119 CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 120 CANADA: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 CANADA: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 CANADA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 CANADA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 125 CANADA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 126 CANADA: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 127 CANADA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 CANADA: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 129 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 130 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 131 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 132 EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136 EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 139 EUROPE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 EUROPE: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 142 EUROPE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 143 EUROPE: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 144 GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 145 GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 146 GERMANY: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 GERMANY: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 149 GERMANY: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 150 GERMANY: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151 GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 GERMANY: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 153 GERMANY: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 154 GERMANY: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 155 GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 156 GERMANY: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 157 GERMANY: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 158 FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 159 FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 FRANCE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 161 FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 162 FRANCE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 163 FRANCE: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 FRANCE: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 165 FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 166 FRANCE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 167 FRANCE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 168 FRANCE: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 169 FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 170 FRANCE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 171 FRANCE: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 172 UK: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 173 UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 UK: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 175 UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 176 UK: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 177 UK: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 178 UK: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 179 UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 180 UK: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 181 UK: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 182 UK: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 183 UK: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 184 UK: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 185 UK: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 186 ITALY: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 187 ITALY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 188 ITALY: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 189 ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 190 ITALY: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 191 ITALY: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 192 ITALY: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 193 ITALY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 194 ITALY: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 195 ITALY: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 196 ITALY: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 197 ITALY: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 198 ITALY: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 199 ITALY: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 200 SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 201 SPAIN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 202 SPAIN: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 203 SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204 SPAIN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 205 SPAIN: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 206 SPAIN: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 207 SPAIN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 208 SPAIN: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 209 SPAIN: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 210 SPAIN: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 211 SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 212 SPAIN: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 213 SPAIN: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 214 ROE: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 215 ROE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 216 ROE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 217 ROE: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 218 ROE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 219 ROE: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 220 ROE: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 221 ROE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 222 ROE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 223 ROE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224 ROE: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 225 ROE: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 226 ROE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 227 ROE: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 228 ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 229 ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 230 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 231 ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 232 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 233 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 234 ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 235 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 236 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 237 ASIA PACIFIC: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 238 ASIA PACIFIC: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 239 ASIA PACIFIC: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 240 ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 241 ASIA PACIFIC: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 242 ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 243 CHINA: CHINA: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 244 CHINA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 245 CHINA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 246 CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 247 CHINA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 248 CHINA: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 249 CHINA: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 250 CHINA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 251 CHINA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 252 CHINA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 253 CHINA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 254 CHINA: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 255 CHINA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 256 CHINA: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 257 JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 258 JAPAN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 259 JAPAN: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 260 JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 261 JAPAN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 262 JAPAN: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 263 JAPAN: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 264 JAPAN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 265 JAPAN: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 266 JAPAN: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 267 JAPAN: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 268 JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 269 JAPAN: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 270 JAPAN: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 271 INDIA: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 272 INDIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 273 INDIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 274 INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 275 INDIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 276 INDIA: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 277 INDIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 278 INDIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 279 INDIA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 280 INDIA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 281 INDIA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 282 INDIA: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 283 INDIA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 284 INDIA: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 285 ROAPAC: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 286 ROAPAC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 287 ROAPAC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 288 ROAPAC: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 289 ROAPAC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 290 ROAPAC: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 291 ROAPAC: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 292 ROAPAC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 293 ROAPAC: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 294 ROAPAC: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 295 ROAPAC: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 296 ROAPAC: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 297 ROAPAC: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 298 ROAPAC: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 299 LATIN AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 300 LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 301 LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 302 LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 303 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 304 LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 305 LATIN AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 306 LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 307 LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 308 LATIN AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 309 LATIN AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 310 LATIN AMERICA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 311 LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 312 LATIN AMERICA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 313 LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 314 BRAZIL: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 315 BRAZIL: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 316 BRAZIL: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 317 BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 318 BRAZIL: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 319 BRAZIL: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 320 BRAZIL: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 321 BRAZIL: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 322 BRAZIL: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 323 BRAZIL: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 324 BRAZIL: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 325 BRAZIL: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 326 BRAZIL: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 327 BRAZIL: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 328 MEXICO: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 329 MEXICO: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 330 MEXICO: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 331 MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 332 MEXICO: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 333 MEXICO: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 334 MEXICO: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 335 MEXICO: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 336 MEXICO: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 337 MEXICO: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 338 MEXICO: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 339 MEXICO: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 340 MEXICO: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 341 MEXICO: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 342 ROLA: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 343 ROLA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 344 ROLA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 345 ROLA: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 346 ROLA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 347 ROLA: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 348 ROLA: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 349 ROLA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 350 ROLA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 351 ROLA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 352 ROLA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 353 ROLA: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 354 ROLA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 355 ROLA: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 356 MEA: CELL CULTURE MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 357 MEA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 358 MEA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 359 MEA: CELL CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 360 MEA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 361 MEA: CELL CULTURE SERA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 362 MEA: CELL CULTURE VESSELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 363 MEA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 364 MEA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 365 MEA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 366 MEA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 367 MEA: CELL CULTURE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 368 MEA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 369 MEA: CELL CULTURE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 370 GLOBAL CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
TABLE 371 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)
TABLE 372 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)
TABLE 373 EXCHANGE RATES (USED FOR THE CONVERSION OF JPY YEN TO USD)
TABLE 374 EXCHANGE RATES (USED FOR THE CONVERSION OF CHF TO USD)
TABLE 375 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)


LIST OF FIGURES (46 Figures)

FIGURE 1 CELL CULTURE MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (ILLUSTRATIVE EXAMPLE)
FIGURE 7 TOP-DOWN APPROACH
FIGURE 8 CELL CULTURE MARKET: CAGR PROJECTIONS FROM SUPPLY SIDE
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE CELL CULTURE MARKET (2020–2025)
FIGURE 10 DATA TRIANGULATION METHODOLOGY
FIGURE 11 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 12 SCENARIOS OF RECOVERY FROM THE COVID-19 IN THE GLOBAL ECONOMY
FIGURE 13 CELL CULTURE MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 14 CELL CULTURE MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 15 CELL CULTURE MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT: CELL CULTURE MARKET
FIGURE 17 CELL CULTURE MARKET TO WITNESS DOUBLE-DIGIT GROWTH RATE DURING THE FORECAST PERIOD
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES COMMANDED THE LARGEST SHARE OF THE APAC CELL CULTURE MARKET IN 2019
FIGURE 19 CHINA IS THE FASTEST-GROWING MARKET FOR CELL CULTURE MARKET DURING THE FORECAST PERIOD
FIGURE 20 ASIA PACIFIC REGION TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD
FIGURE 22 CELL CULTURE MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 23 GROWING NUMBER OF FDA APPROVALS OF PERSONALIZED MEDICINES
FIGURE 24 CELL CULTURE MARKET: VALUE CHAIN ANALYSIS
FIGURE 25 CELL CULTURE MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 26 ECOSYSTEM ANALYSIS OF THE BIOTECHNOLOGY INDUSTRY
FIGURE 27 CONSUMABLES SEGMENT TO DOMINATE THE CELL CULTURE PRODUCTS MARKET IN 2020
FIGURE 28 BIOPHARMACEUTICAL PRODUCTION SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 29 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE THE CELL CULTURE MARKET DURING THE FORECAST PERIOD
FIGURE 30 NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT
FIGURE 31 EUROPE: CELL CULTURE MARKET SNAPSHOT
FIGURE 32 ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT
FIGURE 33 LATIN AMERICA: CELL CULTURE MARKET SNAPSHOT
FIGURE 34 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2020 (TILL OCTOBER)
FIGURE 35 MARKET EVOLUTION FRAMEWORK
FIGURE 36 MNM DIVE-VENDOR COMPARISON MATRIX: CELL CULTURE MARKET
FIGURE 37 GLOBAL CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT
FIGURE 40 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 41 CORNING INCORPORATED: COMPANY SNAPSHOT
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 43 EPPENDORF AG: COMPANY SNAPSHOT
FIGURE 44 FUJIFILM CORPORATION: COMPANY SNAPSHOT
FIGURE 45 LONZA GROUP AG: COMPANY SNAPSHOT
FIGURE 46 SARTORIUS AG: COMPANY SNAPSHOT

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global cell culture market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, manufacturing managers, and related key executives from various key companies and organizations operating in the global cell culture market. The primary sources from the demand side include purchase and sales managers, research organizations, and pharmaceutical and biotechnology companies.

Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and market dynamics.

A breakdown of the primary respondents is provided below:

Cell Culture Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, application, end-user, and region).

Data Triangulation

After arriving at the market size, the total cell culture market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

  • To define, describe, segment, and forecast the cell culture market by product, application, end user, and region
  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, and opportunities)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall cell culture market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the cell culture market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the cell culture market and comprehensively analyze their core competencies2 and market shares
  • To track and analyze competitive developments such as acquisitions; new product launches and upgrades; expansions; collaborations, agreements, and partnerships; and acquisitions of the leading players in the cell culture market
  • To benchmark players within the cell culture market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific cell culture market into Australia, New Zealand, and others.
  • Further breakdown of the Rest of Latin America cell culture market into Argentina, Columbia, Chile, Ecuador, and others.
  • Further breakdown of the Rest of Europe cell culture market into Belgium, Russia, Switzerland, the Netherlands, and others.
COVID-19

Get in-depth analysis of the COVID-19 impact on the Cell Culture Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Cell Culture Market

Request For Special Pricing
Report Code
BT 2561
Published ON
Nov, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cell Culture Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home